From: Reduced risk of post ERCP pancreatitis in statin users
Variable | N (%) |
---|---|
Age | 60.12 (SD 17.5) |
Female | 342 (51.30%) |
Inpatient procedure | 615 (53.01%) |
Statin use | |
High dose | 118 (10.15%) |
Low dose | 245 (21.08%) |
No statin use | 799 (78.8%) |
Multiple ERCPs | 263 (22.63%) |
History of acute pancreatitis | 357 (30.72%) |
History of Post ERCP pancreatitis | 72 (6.2%) |
Native papilla | 790 (68%) |